NorthWest Biotherapeutics Inc (NWBO)

[mc67]

$NWBO Section 2 Financial Information Flash Works?
Item 2.01 Completion of Acquisition or Disposition of Assets

https://www.sec.gov/fast-answers/answersform8khtm.html

An 8-K is a report of unscheduled material events or corporate changes at a company that could be of importance to the shareholders or the Securities and Exchange Commission (SEC). Also known as a Form 8-K, the report notifies the public of events reported including acquisition, bankruptcy, resignation of directors, or a change in the fiscal year. Nov 18 2019

------

https://www.millercanfield.com/resources-SEC-New-Material-Events.html

https://www.hklaw.com/en/insights/publications/2017/04/sec-issues-new-material-event-notices-under-propos

-------------

RE: I agree. But I sometimes wonder if NWBO will be sold on the cheap ($5 or so) and the new company will then release a shit load of PRs regarding UK, Germany, Europe, Canada RA endpoint change acceptance, FDA endpoint changes, Sawston buildout completion, Flaskworks technology implementation, DCVAX-L P3 TLD, etc. The stock will skyrocket...after retail shareholders are out of the picture.

This, perhaps, would explain why NWBO seldom announce new developments that shareholders find via their own dd. Why else wouldn't LP announce any of the above non-TLD new worthy events?! Please don't tell me she wants to prevent all of shorts from taking advantage of shareholders.

Quote:
I agree. However, I think the company will be sold before it can realize that price, as that kind of market cap is years down the line. But who knows?